We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,935.00
Bid: 1,921.00
Ask: 1,923.00
Change: 11.00 (0.57%)
Spread: 2.00 (0.104%)
Open: 1,902.00
High: 1,935.00
Low: 1,902.00
Prev. Close: 1,924.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Pub Owners Rise As Reopening Draws Closer

Tue, 23rd Jun 2020 10:59

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.

----------

FTSE 100 - WINNERS

----------

M&G, up 3.8%. Berenberg started coverage on the investment manager with a Buy rating.

----------

Royal Bank of Scotland, up 2.5%. The state-backed lender said that it has extended the deadline for business customers to take advantage of incentives for switching to other banks, a programme required to increase competition in the UK. The duration of the period under the switching scheme for customers to apply to switch their account will be extended to February 28, 2021, from August 25 and customers will have until June 30, 2021, to complete the switch, the Edinburgh, Scotland-based bank explained. The extension of the account switching scheme do not change the total number of customers targeted to switch under the scheme and, as a result, there is no material change anticipated to the current financial outlook for RBS, it said. The existing requirement on RBS to make a potential further contribution to the switching scheme remains capped at GBP50 million.

----------

FTSE 100 - LOSERS

----------

Hikma Pharmaceuticals, down 7.0% at 2,307.00 pence. Boehringer Ingelheim Invest sold 27.2 million shares in the drugmaker at 2,300p each, and Hikma also will buy back 12.8 million shares owned by Boehringer at the same price, JPMorgan Securities said. The sale price was a 7.3% discount to Hikma's closing price of 2,480 pence on Monday. The US bank said late Monday that Boehringer would sell 28 million Hikma shares via a bookbuild, and as part of the deal Hikma would buy up to GBP295 million of shares from Boehringer. Following the sale, Boehringer no longer holds any shares in Hikma.

----------

Rightmove, down 3.0%. The property portal warned it will take another hit of up to GBP20 million as it cuts prices for estate agents to help weather the coronavirus crisis. Rightmove said despite the positive consumer reaction to the re-opening of the housing market following the lockdown, it takes about three months for housing transactions to complete. The delay is likely to hurt the cash flows of its agents, Rightmove noted. As such, Rightmove said it will offer a 60% discount for August and 40% for September for its agency customers, adding that customers in Wales and Scotland will get a 75% discount for August and a 60% discount for September. In March, Rightmove offered its Agency, New Homes and Commercial customers a 75% discount between April and July. The company said it expects the discounts announced Tuesday to reduce revenue by between GBP17 million to GBP20 million. This is in addition to the GBP65 million to GBP75 million revenue loss forecast as a result of the discounts announced in March.

----------

FTSE 250 - WINNERS

----------

Cranswick, up 4.5%. The food producer said it remains confident in its long-term outlook, as it announced a dividend hike on significant growth in earnings for financial 2020. For the year ended March 28, Cranswick posted revenue of GBP1.67 billion, up 16% from GBP1.44 billion posted the year prior. Pretax profit totalled GBP104.0 million, up 20% from GBP86.5 million. Additionally, the Hull-based company said the average number of pigs processed each week during the recent year increased by 7.9% to 60,000, reaching record levels in March as a result of ongoing higher export demand and increased retail demand during the early stages of the Covid-19 outbreak in the UK. A final dividend of 43.7p per share was declared taking its total annual dividend payout to 60.4p, up 8.1% from 55.9p paid for financial 2019.

----------

Marston's, up 4.3%, Mitchell's & Butlers, up 4.0%, JD Wetherspoon, up 3.0%. UK Prime Minister Boris Johnson is due to set out the results of a review of the two-metre social-distancing rule in the commons on Tuesday - amid a widespread expectations it will be cut to one metre. Much of the focus has been on the hospitality sector - with detailed guidance due on how pubs, bars and restaurants can start gradually to re-open from July 4. "Lately there has been speculation that pubs will reopen early next month, in addition to that, there has been chatter the UK government might reduce the social distancing guidelines from 2m to 1m, and that would be a big boost to the pub trade," said CMC Markets analyst David Madden.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

NCC Group, up 12%. The cybersecurity advisor said it expects revenue and adjusted earnings to exceed analyst consensus in its recently-ended financial year. NCC did note that the Covid-19 outbreak had hurt trading in the third quarter, with "delays, cancellations, and disruption" since the third quarter of its year. These issues "have broadly followed the same pattern as the spread of Covid-19" in the regions where NCC operates. Nonetheless, for its year ended May 31, NCC forecasts that revenue will exceed the GBP243 million consensus figure. Likewise, adjusted earnings before interest and tax is on track "to be comfortably ahead" of the GBP22.3 million consensus. NCC's adjusted figures exclude share-based payments, profit on investment disposal, amortisation of acquired intangibles, and other one-off items.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Scapa Group, down 12%. The healthcare and industrial company said a large exceptional charge resulted in a swing to a loss in financial 2020 and it has decided against paying a final divided to preserve cash amid the Covid-19 pandemic. The Ashton-under-Lyne, England-based company also reported the departure of Chair Larry Pentz and said that it has experienced a significant deterioration in revenue during the first quarter of financial 2021 due to government-enforced lockdowns for some customers. For the year to March 31, Scapa recorded a pretax loss of GBP51.0 million compared with pretax profit of GBP14.9 million. Scapa has decided not to propose a dividend payment as part of its actions to strengthen the liquidity position of company following the impact of Covid-19. The company ended the year with an adjusted net debt of GBP54.4 million versus GBP43.7 million a year ago.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.